Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,646,669
  • Shares Outstanding, K 53,756
  • Annual Sales, $ 110,320 K
  • Annual Income, $ -70,690 K
  • EBIT $ -81 M
  • EBITDA $ -90 M
  • 60-Month Beta 0.27
  • Price/Sales 41.99
  • Price/Cash Flow N/A
  • Price/Book 9.46

Options Overview Details

View History
  • Implied Volatility 80.16% ( -25.22%)
  • Historical Volatility 45.68%
  • IV Percentile 89%
  • IV Rank 59.52%
  • IV High 105.37% on 11/04/24
  • IV Low 43.07% on 08/28/24
  • Put/Call Vol Ratio 0.32
  • Today's Volume 2,612
  • Volume Avg (30-Day) 686
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 40,853
  • Open Int (30-Day) 39,461

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.54
  • Number of Estimates 7
  • High Estimate 0.05
  • Low Estimate -0.82
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.15 +15.78%
on 10/07/24
97.54 -10.80%
on 10/18/24
+8.78 (+11.22%)
since 10/04/24
3-Month
50.29 +73.02%
on 08/07/24
97.54 -10.80%
on 10/18/24
+35.92 (+70.31%)
since 08/05/24
52-Week
43.50 +100.01%
on 11/10/23
97.54 -10.80%
on 10/18/24
+42.38 (+94.96%)
since 11/03/23

Most Recent Stories

More News
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies

/CNW/ -- USA News Group – Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase...

ONCY : 1.1800 (+3.51%)
ACLX : 87.12 (+0.79%)
ONC.TO : 1.63 (+1.87%)
GTHX : 7.15 (unch)
HALO : 58.72 (+0.43%)
SNY : 52.85 (-0.19%)
2 Potential Stocks to Buy From Barchart’s ‘Death Cross’ Indicator

While a security’s short-term moving average dipping below its long-term average warrants caution, this dynamic may also be a contrarian indicator.

IRTC : 86.68 (+6.43%)
ACLX : 87.12 (+0.79%)
Chart of the Day: Arcellx - Reimagining Cell Therapy

The Chart of the Day belongs to the immunotherapy company Arcellx (ACLX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

ACLX : 87.12 (+0.79%)
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 87.12 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 87.12 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 87.12 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 87.12 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 87.12 (+0.79%)
Stocks End Moderately Lower Ahead of Powell’s Testimony to Congress

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.72%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
HAL : 28.53 (+1.42%)
DVN : 39.34 (+0.49%)
PSX : 121.84 (+0.67%)
APA : 23.57 (+0.13%)
CVX : 153.41 (-0.36%)
COP : 109.21 (+0.32%)
Stocks Fall on Chinese Economic Concerns and Wariness Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.73%....

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
APA : 23.57 (+0.13%)
HAL : 28.53 (+1.42%)
DVN : 39.34 (+0.49%)
MRO : 27.60 (+0.33%)
VLO : 132.06 (+1.62%)
CVX : 153.41 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 96.42
2nd Resistance Point 93.81
1st Resistance Point 90.13
Last Price 87.12
1st Support Level 83.83
2nd Support Level 81.22
3rd Support Level 77.54

See More

52-Week High 97.54
Last Price 87.12
Fibonacci 61.8% 76.90
Fibonacci 50% 70.52
Fibonacci 38.2% 64.15
52-Week Low 43.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar